Company intelligence / Profile preview

OptumRx

Eden Prairie, Minnesota, United States
Ownership
Private
Employees
~13000
Development stage
Other
01

Overview

OptumRx manages over 1.5 billion prescriptions annually with specialty pharmacy support for more than 200 complex conditions, achieving medication adherence rates >90% for oral oncology drugs and >$1,000 in average savings for engaged diabetes patients[2].

Therapeutic areas
ImmunologyEndocrinologyNeurologyRare DiseasesOncology
Modalities
Small moleculeBiologicGene therapyCell therapyInfusion drugsSpecialty pharmaceuticals
Industry
Non-Academic Healthcare
02

Partnerships

Epic Pharmacy Network, Inc.Health Action Council

Beyond the preview

Go deeper on OptumRx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OptumRx.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call